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Figure 1. Large thyroid mass: (A) front view, (B) lateral view.
Figure 2. Chest x-ray: (A) 
A big soft tissue mass 
in the neck extending to 
the upper mediastinum 
with significant 
narrowing of the upper 
part of the trachea. 
No obvious pulmonary 
consolidation seen. 
(B) Resolution of neck 
mass and development 
of pulmonary infiltrates 
after chemotherapy.
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Figure 3. (A) Large lymphoid cells with highly atypical nuclei and moderately abundant cytoplasm with few background small 
lymphocytes (Wright-Giemsa stain, x 500). (B) Small group of markedly atypical/malignant large lymphoma cells with hyperchromatic 
nuclei (Papanicolaou stain, x 500).
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A 92t yeartold otherwise healthy female was ditagnosed in another institution with thyroid lymphoma on fine needle aspirate (FNA) five 
years back. The patient repeatedly refused further mant
agement. Due to the rapid increase in the size of her 
tumor, shortness of breath and stridor, she was transt
ferred to our institution and required intubation in the 
intensive care unit. She had 30×15 cm neck mass ext
tending bilaterally and to the upper chest with an ent
gorged neck and chest veins (Figure 1, A and B; Figure 
2A). Her thyroidtstimulating hormone was 11.09 mU/
L (normal range, 0.27 to 4.2 mU/L). Flow immunophet
notyping from the thyroid FNA specimen confirmed a 
CD19, CD20, and CD22 expressing monoclonal Btcell 
population, high forward and side scatter showing surt
face kappa light chain restriction. CD10 and CD5 were 
not cotexpressed. These features and morphology were 
consistent with a large Btcell lymphoma. 
She received cyclophosphamide 500 mg intravenoust
ly and one dose of vincristine 2 mg intravenously and 
dexamethasone 40 mg intravenously for 5 days. Her tut
mor was reduced by 70% after five days. Her shortness 
of breath and stridor increased and chest xtray showed 
infiltrates and then aspiration pneumonia (Figure 2B. 
She developed febrile neutropenia, Klebsiella pneumonir
ae bacteremia, deteriorated rapidly, developed multiple 
organ system failure and died fourteen days after receivt
ing chemotherapy.
DISCUSSION
Primary thyroid lymphoma is relatively rare, accounting 
for only 2% to 5% of all thyroid malignancies with a met
dian age of about 65 years and 60% to 70% of patients 
have diffuse large B cell lymphoma.1t3 Conventional 
treatment is chemotherapy followed by radiation therat
py with a good longtterm outcome of 70% to 90%. Poor 
prognostic factors are older age, advanced stage, diffuse 
large B cell lymphoma, and lack of radiation therapy.1,2 
Our patient was an elderly female with an aggressive 
untreated and neglected lymphoma. The huge size of 
her tumor caused significant local compressive effects. 
Diagnostic material and efforts were limited due to her 
clinical condition. She responded nicely but died due to 
diseasetrelated complications. 
